Central Drug House Private Ltd

Central Drug House Private Ltd - chemicals and materials in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U74899DL1985PTC020363 Incorporated 06 March 1985 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company chemicals and materials MSME · Small
Revenue · FY 2025
₹51.12 Cr
▲ 9% YoY
Net profit · FY 2025
₹10.36 Cr
Net margin 20.3%
EBITDA · FY 2025
₹14.16 Cr
EBITDA margin 27.7%
Authorised capital
₹13 Cr
Registered with MCA
Paid-up capital
₹13 Cr
Issued & subscribed
Open charges
₹90.27 Lakh
Satisfied ₹19.96 Lakh
Company age
41 yrs
Est. 1985
Employees · EPFO
65
Provident fund records

About Central Drug House Private Ltd

Data last updated:

Central Drug House Private Ltd is a private limited company based in New Delhi, Delhi, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 06 March 1985 and has been in existence for over 41 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1985PTC020363. Its GSTIN is 07AAACC2523P1ZN (Delhi). The company holds 4 GST registrations, of which 3 are active.

The company has an authorised share capital of ₹13 Cr and a paid-up capital of ₹13 Cr. It is led by directors including Saurabh Aggarwal and Sachin Aggarwal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 7/28 Vardaan Housansari Road Darygang, New Delhi, Delhi, India – 110002.

As per the financials filed for FY 2025, the company reported a revenue of ₹51.12 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹10.36 Cr (net margin 20.3%) and EBITDA of ₹14.16 Cr (EBITDA margin 27.7%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 15% over five years.

The company has about 65 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹90.27 Lakh and satisfied charges of ₹19.96 Lakh on record. Court records list 5 cases involving the company, including 4 filed by the company and 1 filed against it; 1 case is pending. The company has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹11.5 Cr; the latest was in March 2025. Its 3 peer companies in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger; the largest is Ecmas Construction Chemicals Private Limited with revenue of ₹51.89 Cr. The company has 6 MSME Form 1 returns on record between 2019 and 2024, listing 188 overdue payments to 97 micro and small suppliers.

Central Drug House Private Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0000901). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cdhfinechemical.com.

Company details

CIN U74899DL1985PTC020363
Registration Number 020363
Incorporation Date 06 March 1985
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-01-0000901

Recognitions & Rankings of Central Drug House

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-DL-01-0000901

Contact details

Central Drug House Private Ltd's registered office is in New Delhi, Delhi. Its website is cdhfinechemical.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    7/28 Vardaan Housansari Road Darygang, New Delhi, Delhi, India – 110002
  • Industry
    Chemicals and Materials, Industrial Chemicals

To see the full contact details of Central Drug House Private Ltd, buy the company report.

Comprehensive company report
Central Drug House Private Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Central Drug House is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Central Drug House Private Ltd, buy the company report.

Financials of Central Drug House Private Ltd

FY 2025 filings available

Central Drug House Private Ltd reported revenue of ₹51.12 Cr (up 9% YoY) for FY 2025.

Revenue · FY 2025
₹51.12 Cr ▲ 9%
Net profit · FY 2025
₹10.36 Cr margin 20.3%
EBITDA · FY 2025
₹14.16 Cr margin 27.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 11%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 22%
5 years · compounded
▲ 28%

Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 9% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹14.16 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹10.36 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin27.7%
Net Profit Margin20.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Central Drug House Private Ltd, buy the company report.

Board of directors of Central Drug House Private Ltd

Central Drug House has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Saurabh AggarwalDirector10 Feb 201214 Years 9 MonthsCurrent
Sachin AggarwalDirector05 May 201016 Years 6 MonthsCurrent
Shankar Lal AggarwalDirector16 Mar 198541 Years 8 MonthsCurrent

Peer comparison

Central Drug House Private Ltd is compared with the 3 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Ecmas Construction Chemicals Private Limited₹51.89 Cr (FY 2025)27.0%Hyderabad, Telangana, India
Tarak Chemicals Limited₹51.81 Cr (FY 2025)9.0%Vadodara, Gujarat, India
Galata Chemicals India Private Limited₹51.66 Cr (FY 2024)51.0%Mumbai, Maharashtra, India
Central Drug House Private Ltdthis company₹51.12 Cr (FY 2025)₹10.36 Cr20.3%9.0%New Delhi, Delhi, India

To see the full peer comparison of Central Drug House Private Ltd, buy the company report.

Auditor

Central Drug House Private Ltd is audited by SNR & Company for the financial year 2025.

Auditor firmFinancial yearFirm registration number
SNR & CompanyFY 2025014401N

Shareholding

The shareholding of Central Drug House Private Ltd is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2025FY 2024FY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Central Drug House Private Ltd, buy the company report.

Charges & borrowings

Open charges
₹90.27 Lakh
Satisfied charges
₹19.96 Lakh
Breakdown by lending institutions
Hdfc Bank Limited₹0.90 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Mar 2025101110602Hdfc Bank Limited₹80.3 LakhOpen
23 Jul 2021100479069Hdfc Bank Limited₹9.97 LakhOpen
19 Jun 2023100738877Others₹18 LakhSatisfied
17 Oct 200590331116Sundaram Finance Ltd.₹1.96 LakhSatisfied

To see the full charge records of Central Drug House Private Ltd, buy the company report.

Total charge records: 4 View all charges

Deals & funding

Central Drug House Private Ltd has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹11.5 Cr; the latest was in March 2025.

Total deals
5
Secondary share transfers
4
Funding round
1
Disclosed funding
₹11.5 Cr

Deals on record (5 of 5)

WhenDealAmountParties
Mar 2025Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals
Dec 2012Funding round₹11.5 CrInvestors: 3 individuals
Mar 2012Secondary share transferUndisclosedBuyer: 2 individuals
Seller: Shankar Lal Aggarwal HUF, 3 individuals
Jun 2010Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 4 individuals
May 2010Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 4 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Central Drug House Private Ltd has 6 MSME Form 1 returns on record between 2019 and 2024, listing 188 overdue payments to 97 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 97)

SupplierAmount dueDue sinceReported on
Sulux Phosphates Ltd
Jyoti Som Chemicals
Shree J J Foam Industries
Shree Vishwa Pharma Chem
P J Enterprise

To see the full MSME payment records of Central Drug House Private Ltd, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Central Drug House has 4 GST registrations: 3 active and 1 cancelled or inactive.

Total GSTINs
4
Active
3
Cancelled / inactive
1
GSTINStateStatusRegistered on
07AAACC2523P1ZNDelhiActive01 Jul 2017
24AAACC2523P1ZRGujaratActive01 Jul 2017
02AAACC2523P1ZXHimachal PradeshActive08 Mar 2018

To see the full GST registrations and return filing status of Central Drug House Private Ltd, buy the company report.

Recent activity

Central Drug House Private Ltd has 7 board changes on record since 1985: 4 appointments and 3 cessations. The latest: Heena Sharma was appointed as Company Secretary on 06 Jan 2020.

AGM
Central Drug House Private Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Central Drug House Private Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.80 Cr with Charge ID 101110602 was registered on 26 Mar 2025.
Charges
A charge registered on 19 Jun 2023 via Charge ID 100738877 with Others was fully satisfied on 21 Oct 2023.
Charges
A charge with Others amounted to Rs. 0.18 Cr with Charge ID 100738877 was registered on 19 Jun 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.10 Cr with Charge ID 100479069 was registered on 23 Jul 2021.
Appointed
Heena Sharma was appointed as Company Secretary.
Ceased
Saurabh Aggarwal ceased to be Additional Director.
Appointed
Saurabh Aggarwal was appointed as Director.
Ceased
Omwati Aggarwal ceased to be Director.
Appointed
Sachin Aggarwal was appointed as Director.
Ceased
Sunil Jaikishan Aggarwal ceased to be Director.

4 earlier events are in the company report.

Frequently asked questions

Central Drug House is an active private limited company based in New Delhi, Delhi, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 06 March 1985 (41+ years old) and is registered under CIN U74899DL1985PTC020363.

Central Drug House has 3 current directors:

The latest financial statements of Central Drug House on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Central Drug House is 07AAACC2523P1ZN, registered in Delhi. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 24AAACC2523P1ZR (Gujarat), 02AAACC2523P1ZX (Himachal Pradesh).

The CIN (Corporate Identification Number) of Central Drug House is U74899DL1985PTC020363. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Central Drug House has 5 court cases on record: 4 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.

Central Drug House was incorporated on 06 March 1985, making it 41+ years old. It is registered with the Registrar of Companies, Delhi.

Central Drug House has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹11.5 Cr; the latest was in March 2025.

The peers of Central Drug House by revenue are Ecmas Construction Chemicals Private Limited, Tarak Chemicals Limited, Galata Chemicals India Private Limited, all in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Heena Sharma was appointed as Company Secretary on 06 Jan 2020. Saurabh Aggarwal ceased to be Additional Director on 28 Sep 2012. Saurabh Aggarwal was appointed as Director on 10 Feb 2012. Central Drug House has 7 board changes on record in total.

Yes, Central Drug House is registered as a small enterprise under Udyam registration (number: UDYAM-DL-01-0000901).

Central Drug House has 6 MSME Form 1 returns on record between 2019 and 2024, listing 188 overdue payments to 97 micro and small suppliers. The latest return was filed on 30 Apr 2024.